The Nasdaq, propelled partially by optimism about artificial intelligence (AI), is already in a bull market, as the index had soared 25% so far this year. The S&P 500, which is on the verge of a bull
Medtronic's revenue and profits rose in the fourth quarter. The company's market-topping payout has room to grow.
Now that Johnson & Johnson has spun off its slow-moving consumer health division, its pharmaceutical and medical technology segments are expected to drive growth at a faster pace than usual. Medtronic

My Best Dividend Aristocrats For June 2023

03:34pm, Wednesday, 31'st May 2023
Dividend aristocrats are struggling in 2023, with the ProShares S&P 500 Dividend Aristocrats ETF down 4.71% in May. Three strategies for identifying winning aristocrats include focusing on undervalued
The "Halftime Report" traders give their top picks to watch for the second half.
Investors continue to be optimistic about Medtronic (MDT) on the robust performances of the Neurosurgery and Cardiovascular portfolios.
Although the company posted upbeat Q1 results last week, the stock has declined due to lower-than-expected guidance for fiscal 2024.

2 Healthcare AI Stocks to Buy on the Dip

05:30am, Wednesday, 31'st May 2023
Moderna is working with IBM technology to potentially discover new mRNA medicines. Medtronic is using AI in various specialties and says it could be the key to personalized medicine.

Is It Too Late to Buy Medtronic's Stock?

05:05am, Wednesday, 31'st May 2023
Medtronic's revenue and earnings are steadily increasing. For the past 46 years, the company consistently increased its dividend.
DUBLIN , May 30, 2023 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the 44th annual Goldman Sachs global healthcare confere
Medtronic (MDT) announces that the findings of the EV ICD Pivotal Study reinforce device safety and effectiveness.

Why Medtronic Stock Sank Today

06:12pm, Friday, 26'th May 2023
Some analysts became more bearish on the medical tech specialist's prospects after it published its latest earnings release. That said, there are still pundits who are positive or neutral on the stock
Medtronic's (MDT) latest acquisition will increase its capacity to assist more individuals with diabetes worldwide within a single, seamless Medtronic support ecosystem.
A reversal has been brewing for Medtronic NYSE: MDT and healthcare device makers all year. Increasing procedure volume, supply chain normalization, and innovation drive results and underpinning growth
Strong growth in the Cardiovascular, Medical Surgical, and Neuroscience portfolios, and in Diabetes markets drove Medtronic (MDT) Q4 revenues.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE